Bibliographic evaluation.The goal of this examine is to establish probably the most cited research on lumbar spondylolisthesis and report their affect in backbone discipline. Thomson Reuters Net of Science-Science Quotation Index Expanded was searched utilizing title-specific search “spondylolisthesis.”
All research printed in English language between 1900 and 2019 had been included with no restrictions. The highest 100 cited articles had been recognized utilizing “Occasions cited” arranging articles from excessive to low in accordance with quotation rely. Additional evaluation was made to acquire the next objects: article title, writer’s title and specialty, nation of origin, establishment, journal of publication, yr of publication, citations quantity, examine design.
The quotation rely of the highest 100 articles ranged from 68 to 589. All printed between 1932 and 2016. Amongst 20 journals, Backbone had the very best variety of articles (49), with quotation variety of 6155 out of 13 618. Second ranked was the Journal of Bone and Joint Surgical procedure with 15 articles and whole citations of 3023. With regard to the first writer’s specialty, orthopedic surgeons contributed to the vast majority of high 100 record with 82 articles, and neurosurgery was the second specialty with 11 articles.
The USA had produced greater than half of the record with 59 articles. England was the second nation with 7 articles. Surgical administration of degenerative lumbar spondylolisthesis was the most typical mentioned subject.This text identifies the highest 100 influential articles on lumbar spondylolisthesis and acknowledges an vital facet of data evolution served by main researchers as they guided right this moment’s scientific choice making in spondylolisthesis.
 Anti-Galectin 1 Monoclonal Antibody |
|||
| M00470-1 | BosterBio | 100ug | EUR 397.00 |
|
Description: Rabbit Monoclonal Galectin 1 Antibody. Validated in IP, IF, WB and tested in Human, Mouse, Rat. |
|||
 Anti-Galectin 1/LGALS1 Antibody |
|||
| PB9240-1 | BosterBio | 100ug/vial | EUR 334.00 |
 Polyclonal Goat anti-GST α-form |
|||
| GST-ANTI-1 | Detroit R&D | 50 uL | EUR 280.00 |
 Recombinant Human Galectin-1 Protein |
|||
| PROTP09382-1 | BosterBio | 50ug | EUR 317.00 |
|
Description: Lectins, of either plant or animal origin, are carbohydrate binding proteins that interact with glycoprotein and glycolipids on the surface of animal cells. The Galectins are lectins that recognize and interact with β-galactoside moieties. Galectin-1 is an animal lectin that has been shown to interact with CD3, CD4, and CD45. It induces apoptosis of activated T-cells and T-leukemia cell lines and inhibits the protein phosphatase activity of CD45. Recombinant human Galectin-1 is a 14.5 kDa protein containing 134 amino acid residues. |
|||
 Anti-Galectin-3 Monoclonal Antibody |
|||
| M00621-1 | BosterBio | 100ul | EUR 397.00 |
|
Description: Mouse Monoclonal Galectin-3 Antibody. Validated in IF, IHC, WB and tested in Human, Mouse, Rat. |
|||
 anti-Galectin 1 |
|||
| YF-PA12945 | Abfrontier | 100 ug | EUR 403.00 |
|
Description: Rabbit polyclonal to Galectin 1 |
|||
 Rabbit Polyclonal antibody Anti-CRBN |
|||
| Anti-CRBN | ImmunoStep | 50 µg | EUR 349.00 |
 Anti-Galectin 1 Antibody |
|||
| A00470-2 | BosterBio | 100ug/vial | EUR 294.00 |
 anti- Galectin-1 antibody |
|||
| FNab03314 | FN Test | 100µg | EUR 505.25 |
|
|||
|
Description: Antibody raised against Galectin-1 |
|||
anti- Galectin-1 antibody |
|||
| FNab03315 | FN Test | 100µg | EUR 548.75 |
|
|||
|
Description: Antibody raised against Galectin-1 |
|||
 Anti-Galectin-1 antibody |
|||
| PAab03314 | Lifescience Market | 100 ug | EUR 355.00 |
Anti-Galectin-1 antibody |
|||
| STJ93201 | St John's Laboratory | 200 µl | EUR 197.00 |
|
Description: Rabbit polyclonal to Galectin-1. |
|||
Anti-Galectin-1 antibody |
|||
| STJ98716 | St John's Laboratory | 200 µl | EUR 197.00 |
|
Description: Rabbit polyclonal to Galectin-1. |
|||
) Anti-Galectin 1 (1A8) |
|||
| YF-MA13984 | Abfrontier | 100 ug | EUR 363.00 |
|
Description: Mouse monoclonal to Galectin 1 |
|||
 Anti-Galectin 1/Lgals1 Antibody |
|||
| A00470 | BosterBio | 100ug/vial | EUR 334.00 |
 Anti-Galectin 1 Biotinylated Antibody |
|||
| A00470-Biotin | BosterBio | 50ug/vial | EUR 294.00 |
Anti-Galectin 1/LGALS1 Antibody |
|||
| PA1422 | BosterBio | 100ug/vial | EUR 334.00 |
) anti-Galectin 1 (1E8-1B2) |
|||
| LF-MA10174 | Abfrontier | 100 ug | EUR 363.00 |
|
Description: Mouse monoclonal to Galectin 1 |
|||
Anti-Galectin 1/LGALS1 Antibody |
|||
| PB9240 | BosterBio | 100ug/vial | EUR 334.00 |
 antibody) Anti-galectin-1 (mouse) antibody |
|||
| STJ72519 | St John's Laboratory | 100 µg | EUR 359.00 |
 / Placental Protein 13 (PP13) Monoclonal Antibody) Anti-Galectin-13 (GAL13) / Placental Protein 13 (PP13) Monoclonal Antibody |
|||
| M08143-1 | BosterBio | 100ug/vial | EUR 397.00 |
|
Description: Mouse Monoclonal Galectin-13 (GAL13) / Placental Protein 13 (PP13) Antibody. Validated in IHC and tested in Human. |
|||
 anti-Galectin 3 |
|||
| YF-PA12946 | Abfrontier | 50 ug | EUR 363.00 |
|
Description: Mouse polyclonal to Galectin 3 |
|||
anti-Galectin 3 |
|||
| YF-PA12947 | Abfrontier | 100 ul | EUR 403.00 |
|
Description: Rabbit polyclonal to Galectin 3 |
|||
anti-Galectin 3 |
|||
| YF-PA12948 | Abfrontier | 100 ug | EUR 403.00 |
|
Description: Rabbit polyclonal to Galectin 3 |
|||
 anti-Galectin 8 |
|||
| YF-PA12951 | Abfrontier | 50 ul | EUR 363.00 |
|
Description: Mouse polyclonal to Galectin 8 |
|||
 anti-Galectin 13 |
|||
| YF-PA18585 | Abfrontier | 50 ug | EUR 363.00 |
|
Description: Mouse polyclonal to Galectin 13 |
|||
anti-Galectin 3 |
|||
| YF-PA24079 | Abfrontier | 50 ul | EUR 334.00 |
|
Description: Mouse polyclonal to Galectin 3 |
|||
 anti-galectin 9 |
|||
| YF-PA24081 | Abfrontier | 50 ul | EUR 334.00 |
|
Description: Mouse polyclonal to galectin 9 |
|||
 Polyclonal Goat anti-GST μ-form |
|||
| GST-ANTI-2 | Detroit R&D | 50 uL | EUR 280.00 |
 Polyclonal Goat anti-GST p-form |
|||
| GST-ANTI-3 | Detroit R&D | 50 uL | EUR 280.00 |
 LGALS7 Human, Galectin-7 Human Recombinant Protein, His Tag |
|||
| PROTP47929-1 | BosterBio | Regular: 20ug | EUR 317.00 |
|
Description: Galectin-7 Human Recombinant fused with a 20 amino acid His tag at N-terminus produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 156 amino acids (1-136 a.a.) and having a molecular mass of 17.2kDa. ;The Galectin-7 is purified by proprietary chromatographic techniques. |
|||
 LGALS8 Human, Galectin-8 Human Recombinant Protein, His Tag |
|||
| PROTO00214-1 | BosterBio | Regular: 10ug | EUR 317.00 |
|
Description: LGALS8 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 337 amino acids (1-317 a.a.) and having a molecular mass of 37.9 kDa. The LGALS8 is fused to a 20 amino acid His-Tag at N-terminus and purified by proprietary chromatographic techniques. |
|||
 LGALS3 Human, Galectin-3 Human Recombinant Protein, His Tag |
|||
| PROTP17931-1 | BosterBio | Regular: 25ug | EUR 317.00 |
|
Description: LGALS3 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 270 amino acids (1-250 a.a.) and having a molecular mass of 28.3 kDa._x000D_ The LGALS3 is fused to a 20 amino acid His-Tag at N-terminus and purified by proprietary chromatographic techniques. _x000D_ |
|||
 Anti-human Galectin-3 antibody |
|||
| STJ15100163 | St John's Laboratory | 250 µg | EUR 336.00 |
|
Description: This monoclonal antibody is for studies of antigen expression in cells and tissue sections using immunocytochemistry and immunoprecipitation |
|||
 AssayMax ELISA Kit) Human Galectin-3 (Gal-3) AssayMax ELISA Kit |
|||
| EG3311-1 | AssayPro | 96 Well Plate | EUR 477.00 |
 AssayMax ELISA Kit) Human Galectin-4 (Gal-4) AssayMax ELISA Kit |
|||
| EG3312-1 | AssayPro | 96 Well Plate | EUR 477.00 |
 Recombinant Human Galectin-1 |
|||
| 7-00427 | CHI Scientific | 10µg | Ask for price |
Recombinant Human Galectin-1 |
|||
| 7-00428 | CHI Scientific | 50µg | Ask for price |
Recombinant Human Galectin-1 |
|||
| 7-00429 | CHI Scientific | 1mg | Ask for price |
 Galectin-1, human recombinant |
|||
| 4648-10 | Biovision | EUR 142.00 | |
Galectin-1, human recombinant |
|||
| 4648-1000 | Biovision | EUR 1648.00 | |
Galectin-1, human recombinant |
|||
| 4648-50 | Biovision | EUR 262.00 | |
) Human Galectin-1 (LGALS1) |
|||
| 1-CSB-EP012882HU | Cusabio |
|
|
|
|||
|
Description: Recombinant Human Galectin-1(LGALS1) expressed in E.coli |
|||
Human Galectin-1 (LGALS1) |
|||
| 1-CSB-EP012882HUb1 | Cusabio |
|
|
|
|||
|
Description: Recombinant Human Galectin-1(LGALS1) expressed in E.coli |
|||
 Human Galectin 1 Protein |
|||
| 20-abx066725 | Abbexa |
|
|
|
|||
Bibliographic overview on the state-of-the-art of strontium and zinc primarily based regenerative therapies. Current developments and scientific purposes.
Musculoskeletal issues similar to osteoporosis and rheumatoid arthritis are chargeable for greater than 25ok deaths yearly within the European Union and represent a persistent burden on the people that suffer from this situation. There is no such thing as a medical remedy for these illnesses and there are various therapies utilized which have restricted effectiveness and extreme unwanted effects over time.
Regenerative therapies are being studied as a possible remedy for musculoskeletal illnesses and are recognized for his or her upgrading results of the pure therapeutic processes carried out within the human physique.
It’s believed that each strontium and zinc play a vital function in bone and cartilage tissue formation, which has led many scientists to review the impact of together with these components to advertise tissue formation and inhibit its resorption.
On this overview, a deep evaluation is undertaken of probably the most related developments in strontium and zinc primarily based regenerative therapies that have occurred within the final 5 years, taking into account solely these research reporting vital progress in direction of actual scientific purposes.
This overview brings updated the state-of-the-art of strontium and zinc primarily based regenerative therapies as it’s believed that each have a selling impact on tissue formation and have a vital function inhibiting resorption in musculoskeletal issues.
Handsearching had finest recall however poor effectivity when exporting to a bibliographic software: case examine.
To check the effectiveness and effectivity of strategies used to establish and export convention abstracts right into a bibliographic administration software.
Case examine. The effectiveness and effectivity of strategies to establish and export convention abstracts introduced on the American Society of Hematology (ASH) convention 2016-2018 for a scientific overview had been evaluated.
A reference customary handsearch of convention proceedings was in comparison with: 1) contacting Blood (the journal who report ASH proceedings); 2) key phrase looking out; 3) looking out Embase; 4) looking out MEDLINE through EndNote; and 5) looking out CPCI-S. Effectiveness was decided by the variety of abstracts recognized in contrast with the reference customary, whereas effectivity was a comparability between the sources required to establish and export convention abstracts in comparison with the reference customary.
604 probably eligible and 15 confirmed eligible convention abstracts (abstracts included within the overview) had been recognized by the handsearch. Comparator 2 was the one technique to establish all abstracts and it was extra environment friendly than the reference customary. Comparators 1, and 3-5 missed quite a lot of eligible abstracts.
This examine raises probably regarding questions on trying to find conferences’ abstracts by strategies aside from immediately looking out the unique convention proceedings. Effectivity of exporting could be improved if journals permitted bulk downloads.
 H3N2 Protein) Influenza A (A / Brisbane / 10 / 07) H3N2 Protein |
|||
| abx060621-1mg | Abbexa | 1 mg | EUR 1845.00 |
|
|||
 Influenza A Virus H3N2 Brisbane 10 / 07 Protein |
|||
| 20-abx260509 | Abbexa |
|
|
|
|||
 (A/Brisbane/10/2007) protein IgG, aff pure) Rabbit Anti-Influenza A HA (H3N2, 1-531aa/HA1+HA2) (A/Brisbane/10/2007) protein IgG, aff pure |
|||
| H3N23-A | Alpha Diagnostics | 100 ul | EUR 445.00 |
 Influenza A H3 Antibody |
|||
| abx021977-1mg | Abbexa | 1 mg | EUR 878.00 |
|
|||
|
Influenza A H3 Antibody |
|||
| abx021978-1mg | Abbexa | 1 mg | EUR 878.00 |
|
|||
 Influenza A antibody |
|||
| 10-1103 | Fitzgerald | 500 ug | EUR 349.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-1241 | Fitzgerald | 500 ug | EUR 349.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-1243 | Fitzgerald | 500 ug | EUR 349.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-7866 | Fitzgerald | 1 mg | EUR 403.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-7867 | Fitzgerald | 1 mg | EUR 403.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-I50A | Fitzgerald | 1 mg | EUR 503.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-I50B | Fitzgerald | 1 mg | EUR 392.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-I50C | Fitzgerald | 1 mg | EUR 392.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-I50D | Fitzgerald | 1 mg | EUR 279.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-I50E | Fitzgerald | 1 mg | EUR 279.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-I50F | Fitzgerald | 1 mg | EUR 273.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-I50G | Fitzgerald | 1 mg | EUR 408.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-I50H | Fitzgerald | 1 mg | EUR 541.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-I50I | Fitzgerald | 1 mg | EUR 408.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-I50K | Fitzgerald | 1 mg | EUR 273.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-I50L | Fitzgerald | 1 mg | EUR 300.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-I50M | Fitzgerald | 1 mg | EUR 300.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-I50N | Fitzgerald | 1 mg | EUR 300.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-I50O | Fitzgerald | 1 mg | EUR 300.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-I50P | Fitzgerald | 1 mg | EUR 300.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-I50Q | Fitzgerald | 1 mg | EUR 273.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-I50R | Fitzgerald | 1 mg | EUR 273.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-I50S | Fitzgerald | 1 mg | EUR 273.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-I50T | Fitzgerald | 1 mg | EUR 273.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-I50U | Fitzgerald | 1 mg | EUR 273.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-1096 | Fitzgerald | 500 ug | EUR 208.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-1097 | Fitzgerald | 1 mg | EUR 349.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-1098 | Fitzgerald | 1 mg | EUR 605.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-1099 | Fitzgerald | 1 mg | EUR 605.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-1100 | Fitzgerald | 500 ug | EUR 349.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-1101 | Fitzgerald | 1 mg | EUR 605.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
|
Influenza A antibody |
|||
| 10-1102 | Fitzgerald | 500 ug | EUR 349.00 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
 Influenza A Virus H3 Antigen Antibody |
|||
| abx415738-01mg | Abbexa | 0.1 mg | EUR 718.00 |
|
|||
 Influenza A virus H3 PCR kit |
|||
| PCR-H649-48R | Bioingentech | 50T | EUR 524.40 |
|
|||
|
Description: An conventional PCR kit for detection of Influenza A virus H3 |
|||
|
Influenza A virus H3 PCR kit |
|||
| PCR-H649-96R | Bioingentech | 100T | EUR 669.40 |
|
|||
|
Description: An conventional PCR kit for detection of Influenza A virus H3 |
|||